| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/13/2008 | EP1954309A2 Multiclade hiv vaccines |
| 08/13/2008 | EP1954308A2 Stabilizers for freeze-dried vaccines |
| 08/13/2008 | EP1954307A2 Salmonella based oral vaccines for anthrax |
| 08/13/2008 | EP1954306A2 Compositions comprising yersinia pestis antigens |
| 08/13/2008 | EP1954305A2 Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use |
| 08/13/2008 | EP1954252A2 Nanoparticles for use in immunogenic compositions |
| 08/13/2008 | EP1629004B1 Immunogenic compositions comprising venezuelan equine encephalitis virus replicon vectors and paramyxovirus protein antigens |
| 08/13/2008 | EP1274453B1 Recombinant bcg vaccines against intracellular pathogens and methods for use |
| 08/13/2008 | EP1272636B1 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 08/13/2008 | EP1251835B1 Closure of bacterial ghosts |
| 08/13/2008 | EP1213028B1 Hm1.24 antigen expression potentiators |
| 08/13/2008 | EP1137773B1 Growth factor homolog zvegf3 |
| 08/13/2008 | EP1085906B1 Anti il6 antibodies in the prevention and treatment of inflammatory bowel disease |
| 08/13/2008 | EP1064308B1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 08/13/2008 | EP0942928B2 Subunit respiratory syncytial virus vaccine preparation |
| 08/13/2008 | EP0835133B1 Recombinant poxvirus-rabies compositions and combination compositions and uses |
| 08/13/2008 | EP0831899B1 Recombinant poxvirus-calicivirus compositions and uses |
| 08/13/2008 | EP0669987B1 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain |
| 08/13/2008 | CN101243105A Methods and compositions for targeting IFNAR2 |
| 08/13/2008 | CN101243104A Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system |
| 08/13/2008 | CN101242855A A CA6 antigen-specific cytotoxic conjugate and method of using the same |
| 08/13/2008 | CN101242854A Therapeutic peptides and vaccines |
| 08/13/2008 | CN101240264A Porcine circovirus 2 type inactivated vaccine |
| 08/13/2008 | CN101240022A Cell proliferation inhibitors containing anti-glypican 3 antibody |
| 08/13/2008 | CN101240020A Breast cancer biological molecule marker LASS2 protein, modifying product and medical composition thereof |
| 08/13/2008 | CN101240019A Enterorrhagia colibacillus 0157:H7 Shiga toxin 2A1 subunit active segment Stx2a1 recombination protein, expression method and application |
| 08/13/2008 | CN101239186A Use of soluble lymphotoxin-beta receptors |
| 08/13/2008 | CN101239185A Preventive or therapeutic agent for inflammatory bowel disease comprising IL-6 antagonist as an active ingredient |
| 08/13/2008 | CN101239168A Composition with ease pain anti-inflammatory action |
| 08/13/2008 | CN101239090A Pharmaceutical compositions having appetite suppressant activity |
| 08/13/2008 | CN101239089A Pharmaceutical compositions having appetite suppressant activity |
| 08/13/2008 | CN100410378C Coding hemaagglutinin gene of poultry influenza virus, plant expressing carrier and application thereof |
| 08/13/2008 | CN100410276C Polypeptide |
| 08/13/2008 | CN100410275C Novel anti-igf-ir antibodies and uses thereof |
| 08/13/2008 | CN100410274C Specific anti-human liver cancer phage single-chain antibody HscFv4-16 gene and its uses |
| 08/13/2008 | CN100410268C Expression of immunogenic hepatitis B surface antigens in transgenic plants |
| 08/13/2008 | CN100409898C Combination therapies for B-cell lynphomas comprising administration of anti-CD20 antibody |
| 08/13/2008 | CN100409897C Application of I-type interferon antagonist in preparing medicament for treating inflammatory bowel disease |
| 08/13/2008 | CN100409896C Senile dementia vaccinum and preparing method thereof |
| 08/12/2008 | US7411058 Nucleic acid encoding protein of given sequence; temperature sensitivity, dominant interference, attenuation; vaccines |
| 08/12/2008 | US7411057 Nucleic acids encoding human monoclonal antibodies to CTLA-4 |
| 08/12/2008 | US7411055 Genetic engineering |
| 08/12/2008 | US7411050 Bioassay for detection of receptor activated nuclear factor kappa beta ligand (RANKL); identifying modulator immune and inflammatory response |
| 08/12/2008 | US7411046 Cancerous disease modifying antibodies |
| 08/12/2008 | US7411041 DCRS5 polypeptides |
| 08/12/2008 | US7410954 Adenovirus serotype 30 (Ad30) |
| 08/12/2008 | US7410795 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| 08/12/2008 | US7410787 Diagnosis of Whipple's disease |
| 08/12/2008 | US7410781 Nucleotide sequences coding multimeric protein for use as tool in prevention and treatment of respiratory and allergic disorders |
| 08/12/2008 | US7410779 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 08/12/2008 | US7410758 Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN |
| 08/12/2008 | US7410654 washed, crushed pollen particles and electrolysis reducing water have reduction feature, include active hydrogen is thrown into the super-fine-particle making apparatus, in order to make the active oxygen disappear by means of active H2; whole pollen including shells can be extracted without damage |
| 08/12/2008 | US7410648 Nucleotide sequences coding outer memebrane proteins for use as tools in diagnosis, prevention and treatment of microorganismal infection; immunotherapy; vaccine development |
| 08/12/2008 | US7410647 Vaccines |
| 08/12/2008 | US7410646 Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine |
| 08/12/2008 | US7410645 Moraxella (Branhamella) catarrhalis antigens |
| 08/12/2008 | US7410644 Recombinant pox virus for immunization against tumor-associated antigens |
| 08/12/2008 | US7410643 Materials and methods relating to fusion proteins for inducing an immune response |
| 08/12/2008 | US7410642 Assays and therapies for latent viral infection |
| 08/12/2008 | US7410641 Hybridoma and monoclonal antibodies produced; insulin-like growth factor (IGF); diagnosis, treatment, prevention of diabetes and metabolic disorders |
| 08/12/2008 | US7410640 Treating hypoxia driven angiogenesis or neovascularization; group B beta hemolytic Streptococcus (GBS) |
| 08/12/2008 | US7410639 Neovascularization; platelet derived growth factors; vascular permeability factors; wound healing agents; antitumor/antiproliferative agents; antisense agents; for treatment of intestinal malabsorption syndrome |
| 08/12/2008 | US7410637 Transgenic algae for delivering antigens to an animal |
| 08/12/2008 | CA2376236C Modification of biological elements |
| 08/12/2008 | CA2330235C Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders |
| 08/12/2008 | CA2239799C Murine monoclonal anti-idiotype antibody 11d10 and methods of use thereof |
| 08/12/2008 | CA2131190C Compositions and methods for the treatment of thermal injury |
| 08/09/2008 | CA2618099A1 Antagonists of a non-selective cation channel in neural cells |
| 08/07/2008 | WO2008094969A2 Combination therapy with angiogenesis inhibitors |
| 08/07/2008 | WO2008094942A2 Humanized antibodies against cxcr3 |
| 08/07/2008 | WO2008094674A1 Recombinant bicistronic flavivirus vectors |
| 08/07/2008 | WO2008094276A1 Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins |
| 08/07/2008 | WO2008094183A2 Use of conditional plasmodium strains lacking nutrient transporters in malaria vaccination |
| 08/07/2008 | WO2008094065A1 METHOD AND A THERAPEUTIC AGENT WHICH IS USED FOR TREATING VIRAL HEPATITIS AND BASED ON Enterococcus Faecium M (VKPM B-3490) AND Enterococcus faecium M-3185 (VKPM B- 3491) STRAINS |
| 08/07/2008 | WO2008093976A1 An hbv vaccine and a process of preparing the same |
| 08/07/2008 | WO2008093827A1 Therapeutic agent for central nervous system disorder, and method for treatment of central nervous system disorder |
| 08/07/2008 | WO2008093772A1 Adjuvant for transdermal or transmucosal administration and pharmaceutical preparation containing the same |
| 08/07/2008 | WO2008093756A1 Biological preparation |
| 08/07/2008 | WO2008093331A1 Antibody conjugates for circumventing multi-drug resistance |
| 08/07/2008 | WO2008093280A2 Anti-idiotype monoclonal antibodies as mimotopes of the hiv gp120 antigen |
| 08/07/2008 | WO2008093145A1 Nebulization of vaccines in immunoprophylaxis of avian pox newcastle disease, and avian influenza using avipoxvirus vector vaccines |
| 08/07/2008 | WO2008092996A1 Prevention of allergic sensitization |
| 08/07/2008 | WO2008092992A1 Allergen-binding ige monoclonal antibodies and method for preparing hypoallergens |
| 08/07/2008 | WO2008092902A1 Use of a first house dust mite group 2 allergen for treating allergy to a second house dust mite group 2 allergen |
| 08/07/2008 | WO2008092894A1 Modulators of sclerostin binding partners for treating bone-related disorders |
| 08/07/2008 | WO2008092854A2 Papillomavirus e2 polypeptide used for vaccination |
| 08/07/2008 | WO2008092796A1 Antitumor combination comprising a morpholinyl anthracycline and an antibody |
| 08/07/2008 | WO2008092466A1 Antiviral combination for treatment of hcv & hbv |
| 08/07/2008 | WO2008076960A3 Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases |
| 08/07/2008 | WO2008076960A2 Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases |
| 08/07/2008 | WO2008069889A3 Methods of treating hemolytic anemia |
| 08/07/2008 | WO2008057235A3 Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes |
| 08/07/2008 | WO2008057158A3 Novel neutralizing immunogen (nimiv) of rhinovirus and its use for vaccine applications |
| 08/07/2008 | WO2008054635A3 Proteins for use in diagnosing and treating infection and disease |
| 08/07/2008 | WO2008045601A3 Adenovirus-based genetic vaccines for biodefense |
| 08/07/2008 | WO2008044149A3 Shigella ipad protein and its use as a vaccine against shigella infection |
| 08/07/2008 | WO2007147019A3 Il-17 and il-23 antagonists and methods of using the same |
| 08/07/2008 | WO2007136525A3 Chimeric monoclonal antibody |
| 08/07/2008 | WO2007127290A3 Method for producing viral vaccine and therapeutic peptide antigens |
| 08/07/2008 | WO2007081447A8 Norovirus and sapovirus antigens |